SynAct Pharma Agreement Includes 50/50 Profit-Sharing and $200 Million Sales Milestones
The agreement includes 50/50 profit-sharing and sales milestones linked to $200 million in net sales.
The agreement includes 50/50 profit-sharing and sales milestones linked to $200 million in net sales.